We're excited to announce a major step forward for Beyond Blood Diagnostics! 🌟 Our team is collaborating with the brilliant minds at King's College London to expand our technology into asthma management. 🤝 By maximizing the potential of the 5-part differential in our Full Blood Count, this collaboration will accelerate our R&D and also ensure that patient voices are at the heart of everything we do as we prepare to launch our Patient and Public Involvement and Engagement (PPIE) efforts.⚕ More to come as we continue to innovate and grow! 🌟 #innovation #technology #startups
Beyond Blood Diagnostics
Medical and Diagnostic Laboratories
Empowering chronically ill patients to monitor their health at home
About us
Beyond Blood Diagnostics is working on the latest technologies to advance monitoring the health of chronic patients.
- Website
-
www.beyondblood.co
External link for Beyond Blood Diagnostics
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 2-10 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
London, GB
Employees at Beyond Blood Diagnostics
-
Adam Longley
Seasoned commercial leader with deep experience of marketing and product management in Med Tech and Point of Care technologies
-
Muir Sanderson
Executive Coach and Senior Advisor
-
Lindsey Cook
Healthcare Consultancy Director, Chairperson & Portfolio Non-Executive Director
Updates
-
Ministers and Medical Miracles Unite! 🤝 This week, we had the pleasure of welcoming the MedTech Innovation Directorate and Policy Adviser from the Department of Health and Social Care (DHSC) and the Department for Science, Innovation and Technology (DSIT) to Beyond Blood Diagnostics. Our research powerfully supports the UK Government's initiatives in enhancing early disease detection, reducing waiting times, and driving innovation in point-of-care diagnostics — aligning with national goals to improve patient care efficiency, expedite clinical trials, and support integrated care models. Innovation and collaboration are at the heart of our mission! 💼 #Innovation #Healthcare #LifeSciences
-
Blood Ties & Bold Strides 🤝 Imperial College London's DNA runs deep at Beyond Blood Diagnostics (we're a spin-out, after all!). This heritage has fueled our journey from groundbreaking ideas to innovative realities. Today, we're proud to be featured by Imperial as one of their successful and trailblazing startups, redefining healthcare boundaries. Discover the full story here: https://lnkd.in/eHmMsYAR We're building incredible partnerships across Europe, North America, and Asia, expanding what's possible in healthcare and extending our reach across the globe. Watch this space for more exciting developments as we leverage this global network to disrupt the diagnostics industry! #imperial #innovation #startups
-
🚀 Exciting News! 🚀 We're delighted to welcome Ahmed Taher to our team as a Senior Design Engineer! 🎉 Ahmed is a microfluidics wizard, with impressive experience in: - Bio applications 🧬 - Microfabrication 🔬 - Lab on a chip technology 🧪 His talent for developing innovative and impactful solutions will be invaluable as we continue to push the limits of diagnostic and healthcare technology. Welcome aboard, Ahmed! We're looking forward to achieving remarkable milestones together. 🌟 #NewHire #Innovation #Technology #BeyondBloodDiagnostics
-
Today the National Research Council of Canada has announced their investment for Canada-UK quantum collaborations. We are proud to have been selected as the only company to receive funding for the development of new quantum technologies in the diagnostic sector from this initiative. This is testament to how cutting technology is enabled by cross-border collaborations between innovative startups, SMEs and academia. Shabir Barzanjeh Innovate UK Applied Quantum Materials Inc. https://lnkd.in/e55DeR_R
National Research Council of Canada announces funding for Canada–UK quantum collaborations
canada.ca
-
A great end of year, with a £2.4m raised in a combination of equity and non dilutive funding to bring us to a production ready prototype. Today, tens of millions of people require frequent blood tests to manage their health. Our mission is to deliver a portable device that can deliver blood tests at home, transforming how patients living with chronic diseases manage their treatment and symptoms. 2024 will bring some early clinical evidence and usability testing to ensure we put patients in the front seat of the design cycles. Happy new year from the BBD team (including Timmy Green, who couldn't join on this occasion)
-
Early detection and personalised treatments in cancer are now being developed using intelligent devices. Together with our partners Physiomics plc and the NHS Blackpool Hospital Trust, we are tackling precision medicine challenges in cancer therapy. This investment from UKRI is pivotal in bringing this technology one step closer to those who need it most! https://lnkd.in/e3GZjQBE
£10 million invested in cancer and chronic health conditions
ukri.org